Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair
Primary Purpose
Inguinal Hernia
Status
Unknown status
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
bupivacaine
saline
Sponsored by
About this trial
This is an interventional treatment trial for Inguinal Hernia
Eligibility Criteria
Inclusion Criteria:
- age above 18 years
- unilateral primary inguinal repair
- open surgery a.m. Lichtenstein
- informed consent
Exclusion Criteria:
- age below 18 years
- secondary surgery
- laparoscopic surgery
- lack of communicative skills
Sites / Locations
- Copenhagen University Hospital BispebjergRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
bupivacaine
saline
Arm Description
perineural bupivacaine 5 mg/ml 20 ml
perineural isotonic saline 20 ml
Outcomes
Primary Outcome Measures
pain at mobilization using 100 mm VAS
Secondary Outcome Measures
pain at rest using 100 mm VAS
perceived illness
using short form-8 index
ability of daily living
using the Barthel/100 index
amount of analgesics
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01326039
Brief Title
Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair
Official Title
Does Ultrasound-guided Ilioinguinal-iliohypogastric Block Improve Postoperative Pain Outcome After Unilateral Inguinal Hernia Repair?
Study Type
Interventional
2. Study Status
Record Verification Date
April 2010
Overall Recruitment Status
Unknown status
Study Start Date
May 2010 (undefined)
Primary Completion Date
June 2011 (Anticipated)
Study Completion Date
July 2011 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Bispebjerg Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Aim: To investigate whether ultrasound-guided perineural administration of 20 ml bupivacaine 5 mg/ml vs 20 ml isotonic saline at the ilioinguinal-iliohypogastric nerves have a clinically analgesic effect after unilateral open inguinal hernia repair.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inguinal Hernia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
bupivacaine
Arm Type
Active Comparator
Arm Description
perineural bupivacaine 5 mg/ml 20 ml
Arm Title
saline
Arm Type
Placebo Comparator
Arm Description
perineural isotonic saline 20 ml
Intervention Type
Drug
Intervention Name(s)
bupivacaine
Intervention Description
perineural bupivacaine 5 mg/ml 20 ml
Intervention Type
Drug
Intervention Name(s)
saline
Intervention Description
perineural isotonic saline 20 ml
Primary Outcome Measure Information:
Title
pain at mobilization using 100 mm VAS
Time Frame
within the first 24 hours postoperatively
Secondary Outcome Measure Information:
Title
pain at rest using 100 mm VAS
Time Frame
within 24 hours postoperatively
Title
perceived illness
Description
using short form-8 index
Time Frame
within 24 hours postoperatively
Title
ability of daily living
Description
using the Barthel/100 index
Time Frame
within 24 hours
Title
amount of analgesics
Time Frame
within 24 hours postoperatively
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age above 18 years
unilateral primary inguinal repair
open surgery a.m. Lichtenstein
informed consent
Exclusion Criteria:
age below 18 years
secondary surgery
laparoscopic surgery
lack of communicative skills
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, MD
Organizational Affiliation
Copenhagen University Hospital Bispebjerg, Denmark
Official's Role
Study Chair
Facility Information:
Facility Name
Copenhagen University Hospital Bispebjerg
City
Copenhagen
State/Province
NV
ZIP/Postal Code
2400
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Finn Bærentzen, MD
Phone
35313531
Email
finn-baerentzen@tdcadsl.dk
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, MD
Phone
35313531
Ext
4496
Email
kjen0067@bbh.regionh.dk
First Name & Middle Initial & Last Name & Degree
Finn Bærentzen, MD
First Name & Middle Initial & Last Name & Degree
Jens Børglum, MD
First Name & Middle Initial & Last Name & Degree
Kenneth Jensen, MD
12. IPD Sharing Statement
Learn more about this trial
Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair
We'll reach out to this number within 24 hrs